Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation. (NAVA-VNI)

University Hospital of Bordeaux

Status: Completed

Conditions: Acute Respiratory Distress

Treatments: Device: Noninvasive pressure support ventilation (NPSV); Device: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).

Study type: Interventional

Funder types: Other

Identifiers

NCT01928238

CHUBX 2011/27

Details and patient eligibility

About

The purpose of this study is to compare inspiratory effort, comfort, gas exchange and patient ventilator synchrony during non-invasive neurally adjusted ventilatory assist or pneumatically triggered and cycled-off noninvasive pressure support ventilation (NPSV), in patient at risk of respiratory distress after extubation.

Full description

Reintubation, which occurs after planned extubation, is a relevant consequence of respiratory failure after extubation. The early use of noninvasive pressure support ventilation averted respiratory failure after extubation in patients at increased risk. However patient tolerance to the technique is a critical factor determining its success. One of the key factors determining tolerance to Non Invasive Ventilation (NIV) is optimal synchrony between the patient's spontaneous breathing activity and the ventilator's settings, known as patient ventilator interaction. Optimal patient-ventilator synchrony during NIV can prove very difficult to achieve due to the presence of leaks, the type of interface which can interfere with various aspects of ventilator function. Patient ventilator synchrony during NPSV can be compromised when using conventional pneumatic triggering, with the ventilator-delivered inspiratory support starting after the patient's inspiratory effort. The switch from inspiration to expiration (cycling-off) should, ideally, coincide with the end of the patient's inspiratory effort. However greater asynchrony at the end of inspiration, with the ventilator cycling off either too early or too late compared to the end of the patient's inspiratory effort can be observed during NPSV. A possible solution is to replace the pneumatic triggering with neural triggering and cycling off using the diaphragm electrical activity (Eadi). Neurally adjusted ventilatory assist (NAVA) uses the electrical activity of the diaphragm to control the timing and pressure of the ventilation delivered. The ventilator is triggered, limited and cycled-off directly by Eadi. The Eadi is measured by a multiple array oesophageal electrode. The array of bipolar electrodes can be mounted on a feeding tube, which is routinely introduced in critically ill patients.

Enrollment: 13 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients intubated for 48 h or more

• Patients who tolerated a 120-min spontaneous breathing trial after recovery from their acute disease with no signs of respiratory failure

• Patients at high risk for respiratory after extubation were enrolled if they had at least two of the following risk factors for respiratory failure after extubation:

  • age older than 65 years
  • Chronic obstructive pulmonary disease,
  • heart failure as the cause for intubation
  • An Acute Physiology and Chronic Health Evaluation (APACHE)-II score greater than 12 on the day of extubation.

Exclusion criteria

• Age younger than 18 years
• Head trauma or surgery
• Recent gastric or oesophageal surgery
• Active upper gastrointestinal bleeding
• Excessive amount of respiratory secretions
• Poor cooperation
• Decision to limit life-supporting treatments in the ICU
• Tracheostomy or other upper airway disorders
• Lack of collaboration
• Do not resuscitate order or any decision to limit therapeutic effort in the ICU.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

13 participants in 2 patient groups

Arm 1

Experimental group

Description:

Patients will have two 20-minute noninvasive periods : Noninvasive neurally adjusted ventilatory assist (NIV-NAVA) and then Noninvasive pressure support ventilation (NPSV)

Treatment:

Device: Noninvasive pressure support ventilation (NPSV)

Device: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).

Arm 2

Experimental group

Description:

Patients will have two 20-minute noninvasive periods : Noninvasive pressure support ventilation (NPSV) and then Noninvasive neurally adjusted ventilatory assist (NIV-NAVA)

Treatment:

Device: Noninvasive pressure support ventilation (NPSV)

Device: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).